Search hospitals > Massachusetts > Boston

Dana Farber Cancer Institute

Claim this profile
Boston, Massachusetts 02215
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Leukemia
Conducts research for Lymphoma
3428 reported clinical trials
267 medical researchers
Photo of Dana Farber Cancer Institute in BostonPhoto of Dana Farber Cancer Institute in BostonPhoto of Dana Farber Cancer Institute in Boston

Summary

Dana Farber Cancer Institute is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Tumors, Leukemia, Lymphoma and other specialties. Dana Farber Cancer Institute is involved with conducting 3,428 clinical trials across 1,341 conditions. There are 267 research doctors associated with this hospital, such as Susan Chi, MD, Haeseong Park, MD, Geoffrey I. Shapiro, and Ryan Sullivan, MD.

Area of expertise

1Cancer
Global Leader
Dana Farber Cancer Institute has run 535 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Dana Farber Cancer Institute has run 484 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 negative

Top PIs

Clinical Trials running at Dana Farber Cancer Institute

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Dana Farber Cancer Institute?
Dana Farber Cancer Institute is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Tumors, Leukemia, Lymphoma and other specialties. Dana Farber Cancer Institute is involved with conducting 3,428 clinical trials across 1,341 conditions. There are 267 research doctors associated with this hospital, such as Susan Chi, MD, Haeseong Park, MD, Geoffrey I. Shapiro, and Ryan Sullivan, MD.
Where is Dana Farber Cancer Institute located?
The Dana Farber Cancer Institute is situated at 450 Brookline Ave, Boston, MA 02215, within the Longwood Medical Area. For access from the north, utilize I-93, the Tobin Bridge (Route 1), and Route 28, directing towards Storrow Drive, then proceed for 1.5 miles. Follow the exit for Kenmore Square/Fenway, Route 1S, stay in the far left lane, and continue onto Boylston Street (outbound), then bear slight left onto Brookline Avenue, and turn left onto Jimmy Fund Way to find the parking garage entrance on the right.
Who should I call to ask about financial aid or insurance network?
**Dana Farber Cancer Institute Contact Information:** - **Patient Billing Solutions Team:** For general financial inquiries and assistance with the Patient Financial Assistance program, call 617-632-3795. - **Shapiro Center for Patients and Families:** For insurance and financial information questions, contact 617-632-3750. - **International Office:** Specialized support for international patients is available. - **Language Assistance:** Spanish-speaking patients can call 617-632-3673. For all other languages, please call 617-632-6366. **Address:** 450 Brookline Ave., Boston, MA 02215-5450.
What insurance does Dana Farber Cancer Institute accept?
The Dana Farber Cancer Institute accepts a wide range of insurance plans, such as Aetna, Allways Health Partners, AmeriHealth, Anthem, Cigna, Humana, Oscar, and UnitedHealthcare. It is now an in-network provider for the Boston Medical Center HealthNet Plan (BMCHP), catering to Massachusetts residents, including MassHealth members from marginalized communities, individuals with disabilities, and seniors. The hospital offers specialized services for international patients and financial counseling for uninsured or low-income individuals to explore coverage options.
What awards or recognition has Dana Farber Cancer Institute received?
The Dana-Farber Cancer Institute in Boston, Massachusetts, is renowned for its exceptional research and care in the field of cancer. It has been recognized as one of the most noteworthy companies and non-profits led by women in Massachusetts. Furthermore, 24 of its researchers have been acknowledged as Highly Cited Researchers, underscoring their significant global impact on cancer research.